Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Williams, John D ^a   Craig, Kathrine J ^a   Topley, Nicholas ^a   Williams, Geraint T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Peritoneal dialysis; Submesothelial compact collagenous zone; Uremia

Indexed keywords

GLUCOSE; GLUCOSE DEGRADATION PRODUCT; PERITONEAL DIALYSIS FLUID; TOLONIUM CHLORIDE; BIOMATERIAL; DIALYSIS FLUID;

BIOCOMPATIBILITY; CONFERENCE PAPER; CONTROLLED STUDY; DIALYSIS MEMBRANE; FLUID BALANCE; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; KIDNEY TRANSPLANTATION; MESOTHELIUM; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; THICKNESS; TREATMENT FAILURE; UREMIA; VENULE; CHRONIC KIDNEY FAILURE; METHODOLOGY; PATHOLOGY; REVIEW;

BIOCOMPATIBLE MATERIALS; DIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM;

EID: 0037407245     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.46.x     Document Type: Conference Paper

References (12)

1. COLES GA, WILLIAMS JD: What is the place of peritoneal dialysis in the integrated treatment of renal failure? Kidney Int 54:2234-2240, 1998
2. FENTON SS, SCHAUBEL DE, DESMEULES M, et al: Haemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
3. VAN BISSEN W, VANHOLDER RC, VEYS N, et al: An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 11:116-125, 2000
4. DAVIES SJ, PHILLIPS L, GRIFFITHS AM, et al: What really happens to people on long-term peritoneal dialysis? Kidney Int 54:2207-2217, 1998
5. DI PAOLO N, SACCHI G, DE MIA M, et al: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 44:204-211, 1986
6. RUBIN J, ROGERS WA, TAYLOR HM, et al: Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 92:7-13, 1980
7. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphological changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
8. HONDA K, NITTA K, HORITA S, et al: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14:1541-1549, 1999
9. HONDA K, NITTA K, HORITA H, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
10. MATEIJSEN MA, VAN DER WAL AC, HENDRIKS PM, et al: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
11. RIPPE B, SIMONSEN O, WIESLANDER A, et al: Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 17:27-34, 1997
12. JONES S, HOLMES CJ, KREDIET RT, et al: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59:1529-1538, 2001